Loading briefing details...
Loading briefing details...
News Abstract
By: NewsAbstract Editorial Team
Topic: Business, Health
March 26, 2026
Dr. Christine Grogan's appointment as CCO signifies a strategic move by New Horizon Medical Solutions to accelerate market penetration and innovation in advanced wound care. Her proven leadership in commercial strategy is crucial for expanding reach, strengthening partnerships, and ultimately enhancing patient outcomes through cutting-edge solutions.
LAS VEGAS, NV – New Horizon Medical Solutions (NHMS), a leader in advanced healthcare solutions, announces the appointment of Dr. Christine Grogan, DHA, as Chief Commercial Officer (CCO). This strategic move underscores NHMS’s commitment to expanding commercial capabilities and market impact within the wound care landscape. Dr. Grogan is a results-driven executive renowned for transforming organizations and delivering sustained revenue growth across the pharma, biotech, and medical device sectors.
In her pivotal CCO role, Dr. Grogan will lead NHMS's entire commercial organization, encompassing sales, marketing, and strategic partnerships. Her expertise will drive the company's growth agenda, strengthen market positioning, and ensure differentiated value delivery to clients, providers, and patients. Will Hall, CEO of New Horizon Medical Solutions, stated, "Christine is a decisive leader with the strategic clarity and operational focus we need. We're excited to have her on board."
Dr. Grogan expressed enthusiasm, "I'm excited to join NHMS at a pivotal moment. The company has clear vision and strong momentum, and I look forward to expanding our reach and deepening relationships with healthcare providers." NHMS continues its mission to deliver cutting-edge medical solutions, including biologically derived human placental allograft products, enhancing clinical outcomes and transforming the patient experience in advanced wound care.